Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00756665Recruiting

Prostate Active Surveillance Study

Role: collaborator

NCT04472338Recruiting

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

Role: collaborator

NCT03824535Phase 2Completed

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Role: collaborator

NCT04179604Phase 2Unknown

Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)

Role: collaborator

NCT01121640Not ApplicableCompleted

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

Role: collaborator

All 5 trials loaded